Full-Time

Compliance Manager

Director

Posted on 7/17/2024

Altos Labs

Altos Labs

501-1,000 employees

Biotechnology focused on cell rejuvenation research

Compensation Overview

$261.8k - $354.2kAnnually

Expert

Oakland, CA, USA

Onsite role with 5-15% travel required including international travel.

Category
Public Health
Biology & Biotech
Requirements
  • Bachelor’s degree with at least 10 years of compliance experience in a biotech or pharmaceutical company.
  • One or more relevant certifications such as Certification of Certified Compliance and Ethics Professional (CCEP), Certified Healthcare Compliance (CHC), and the like.
Responsibilities
  • Accomplishing the global and local implementation, and continued enhancements, of the company policies and procedures to ensure the company complies with all applicable laws, regulations, and industry standards.
  • Conducting risk assessments. Collaborating with internal stakeholders as appropriate in risk remediation, mitigation, and prevention practices implementation.
  • Overseeing and managing the company’s ethics hotline.
  • Conducting investigations of alleged violations of the company’s ethical standards or non-compliance with applicable laws, regulations, and company policy.
  • Ensuring that investigations follow the approved process and are lawful, objective, and thorough and that the resulting findings are accurate, clear, and concise.
  • Tracking and reporting results of investigations and the corrective actions taken to as needed. Support the CCO in the interpretation of findings/trends and carry out corrective action and retraining as needed.
  • Conducting applicable monitoring and auditing with a strong understanding of relevant internal controls and risk assessment methodologies and routine reporting of progress.
  • Developing and delivering training internally.
  • Creating and conducting engaging and meaningful communication materials that meet the internal stakeholders where they are and embed a speak-up culture.
  • Coaching and collaborating with internal stakeholders to develop focused and relatable training and communications.
  • Ensuring that systems and records are compliant with relevant global and local requirements.
  • Providing guidance expertise regarding regulatory, privacy, and compliance issues, including regulations and practices related to global and local GxP requirements, fraud and corruption, transparency, and competition.
  • Collaborating with the information security function to ensure alignment between security and compliance (including privacy) programs including policies, practices, and investigations.
  • Collaborating with the Data Privacy Officer on assessments, mitigations, remediations, initiatives, standard setting, and training.
  • Monitoring the legal, regulatory, and business developments and industry compliance best practices to evolve the compliance and privacy program through ensuring appropriate practices, processes, systems, and tools are in place and maintained to always support the business and anticipate emerging compliance trends.
  • Leading specific functional or company initiatives as assigned.
  • Acting as an enthusiastic and approachable ambassador for ethics and compliance topics, resources, and special initiatives.
  • Other duties as assigned by the Chief Compliance Officer.

Altos Labs specializes in biotechnology with a focus on cell rejuvenation, aiming to restore cell health and resilience to reverse diseases and injuries. They utilize cellular rejuvenation programming to enhance cells' ability to resist stressors that lead to illness. The company differentiates itself through its dedicated research and development efforts, collaborating with healthcare providers and research institutions to create effective treatments. Altos Labs' goal is to improve patients' quality of life by providing solutions that can alleviate the effects of various health conditions.

Company Size

501-1,000

Company Stage

Seed

Total Funding

$3.2B

Headquarters

Los Altos, California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased investment in longevity research supports Altos Labs' growth potential.
  • Growing demand for innovative treatments positions Altos Labs at the market forefront.
  • AI and machine learning expedite the development of new cellular rejuvenation therapies.

What critics are saying

  • Ethical concerns about life extension may lead to regulatory challenges.
  • Intensifying competition in the biotech sector could dilute Altos Labs' market share.
  • Reliance on high-profile investors may pressure Altos Labs to deliver rapid results.

What makes Altos Labs unique

  • Altos Labs focuses on cellular rejuvenation to reverse diseases and improve healthspan.
  • The company collaborates with leading scientists and research centers for innovation.
  • Altos Labs leverages biotechnology to develop tailored cell rejuvenation therapies.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
The Spirits Business
Mar 27th, 2024
Altos is UK off-trade's leading 100% agave Tequila

In London, Altos recently launched its inaugural Margarita Masters competition for bartenders, with the hope of taking it nationwide in the future.

Startup Italia
Nov 17th, 2023
«Ad Altos Labs Vogliamo Creare Una Nuova Medicina». Simone Bianco E L’Avventura Nella Venture Californiana

«Per uno scienziato Elon Musk ha senz’altro meno appeal di un Premio Nobel». Se poi i Nobel sono quattro, tutti seduti nel board of directors della startup per cui lavori, potremmo dire non esserci partita. Tra questi, ad esempio, Jennifer Doudna, che ha vinto grazie al lavoro sull’editing genetico Crispr nel 2020. Simone Bianco, employee numero 27 di Altos Labs con sede a San Francisco, è Principal Investigator e Director of Computational Biology in quella che lui preferisce definire una venture, non una startup. Nel corso dell’intervista gli abbiamo chiesto di Musk e dei suoi piani per salvare l’umanità, anche con Neuralink, ma la discussione ha rapidamente virato verso altre figure, più specializzate nella materia in questione. Altos Labs, dunque

The Recursive
Mar 8th, 2023
Finding The Fountain Of Youth: Meet The Startups Pioneering Longevity Solutions

If technology allowed humanity to live forever in the future, would you take the ticket? We asked our readers recently and were surprised to see the balance tilt towards “No” (60% of respondents). One answer was hidden in a comment from one of our readers – they would want to live forever, yet only if they stayed young. Among others, living long worries people as it is associated with getting old and suffering from various diseases.Yet if technology allows us to extend our life spans it will also likely improve our health spans. According to demographers, children today have a better chance of living up to 100 years old than ever before. But their lives won’t be just longer, they will also benefit from day-to-day technological advances aimed at improving their well-being, preventing diseases, and keeping their minds and bodies in shape.Slowing aging presents an economic opportunity, too. In the US, an estimate shows that just one to two years increase in life expectancy are worth between $7 trillion and $38 trillion

GeekWire
Apr 21st, 2022
Juno Therapeutics Vets Steve Harr And Hans Bishop On Building Startups, Working With Tech, And More

Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell therapy company Juno Therapeutics, where Bishop was CEO and Harr was COO and CFO.

Fierce Biotech
Apr 18th, 2022
Biotech's top 10 money raisers of 2021

After a bustling, record-setting 2020 for private biotechs raising cash, the bar heading into 2021 was exceptionally high. Turns out, private investors elected to just take the bar and do pull-ups, breaking 2020’s record by a whopping 26%.  | 2021 marked the second consecutive year of record-breaking private financing for biotechs, with more than $28 billion raised. The total haul is a 26% increase from 2020, and the stunning dollar amounts came even as the public market depreciated throughout the year. Here's our look at the 10 biotechs that raked in the largest VC investments.

INACTIVE